Launching Genetics, Genomics & Molecular Oncology: A New Scientific Area in PCMB

Authors

  • Alberto Guevara Tirado Investigador independiente Author

DOI:

https://doi.org/10.68178/taf0e413

Keywords:

Genetic, Genomics, Molecular oncologu, Bioinformatics, Precision medicine

Abstract

Advances in genetics, genomics, molecular oncology, epigenetics, bioinformatics, and precision medicine are transforming the understanding of human disease and creating new opportunities for diagnosis, prognosis, prevention, and treatment. Perspectivas en Ciencias Médicas y Biológicas is establishing Genetics, Genomics & Molecular Oncology as a new thematic scientific area intended to provide an interdisciplinary space for research at the interface of molecular biology and medicine. The journal welcomes original research, reviews, methodological contributions, brief reports, and scientific perspectives addressing genomics, transcriptomics, epigenetics, non-coding RNAs, cancer biology, molecular biomarkers, pharmacogenomics, bioinformatics, multi-omics, and translational research. This initiative also seeks to promote international collaboration, methodological rigor, research integrity, and opportunities for emerging investigators.

Downloads

Download data is not yet available.

References

1. Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31-46. doi:10.1158/2159-8290.CD-21-1059.

2. Mosele MF, Westphalen CB, Stenzinger A, et al. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group. Ann Oncol. 2024;35(7):588-606. doi:10.1016/j.annonc.2024.04.005.

3. Aldea M, Friboulet L, Apcher S, et al. Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision? ESMO Open. 2023;8(5):101642. doi:10.1016/j.esmoop.2023.101642.

4. Sosinsky A, Ambrose J, Cross W, et al. Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. Nat Med. 2024;30(1):279-289. doi:10.1038/s41591-023-02682-0.

5. Lotter W, Hassett MJ, Schultz N, Kehl KL, Van Allen EM, Cerami E. Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions. Cancer Discov. 2024;14(5):711-726. doi:10.1158/2159-8290.CD-23-1199.

Downloads

Published

2026-08-28